Shares of Silicon Laboratories Inc. (NASDAQ:SLAB – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight research firms that are currently covering the firm, MarketBeat reports. Four research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $140.00.
Several research analysts have recently weighed in on the stock. Needham & Company LLC reiterated a “buy” rating and set a $150.00 price objective on shares of Silicon Laboratories in a report on Thursday, July 25th. StockNews.com upgraded shares of Silicon Laboratories to a “sell” rating in a report on Wednesday, October 30th.
Get Our Latest Stock Analysis on Silicon Laboratories
Insider Activity at Silicon Laboratories
Institutional Trading of Silicon Laboratories
A number of hedge funds have recently made changes to their positions in SLAB. State of Michigan Retirement System raised its stake in shares of Silicon Laboratories by 2.6% during the first quarter. State of Michigan Retirement System now owns 7,797 shares of the semiconductor company’s stock valued at $1,121,000 after purchasing an additional 200 shares during the period. Retirement Systems of Alabama raised its stake in shares of Silicon Laboratories by 0.5% during the first quarter. Retirement Systems of Alabama now owns 50,155 shares of the semiconductor company’s stock valued at $7,208,000 after purchasing an additional 253 shares during the period. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Silicon Laboratories by 12.5% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 80,745 shares of the semiconductor company’s stock valued at $11,605,000 after purchasing an additional 8,950 shares during the period. BNP Paribas Financial Markets raised its stake in shares of Silicon Laboratories by 5.9% during the first quarter. BNP Paribas Financial Markets now owns 44,997 shares of the semiconductor company’s stock valued at $6,467,000 after purchasing an additional 2,526 shares during the period. Finally, Fidelis Capital Partners LLC acquired a new stake in shares of Silicon Laboratories during the first quarter worth approximately $55,000.
Silicon Laboratories Price Performance
Silicon Laboratories stock opened at $104.74 on Friday. The stock has a market capitalization of $3.38 billion, a P/E ratio of -16.89 and a beta of 1.20. Silicon Laboratories has a 12-month low of $90.65 and a 12-month high of $154.91. The firm’s 50-day moving average is $112.84 and its two-hundred day moving average is $115.65.
Silicon Laboratories Company Profile
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Read More
- Five stocks we like better than Silicon Laboratories
- What Does a Stock Split Mean?
- Intel: Is Now the Time to Be Brave?
- 5 Top Rated Dividend Stocks to Consider
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to buy stock: A step-by-step guide for beginners
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.